Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy (NCT05649852) | Clinical Trial Compass
RecruitingNot Applicable
Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy
France192 participantsStarted 2023-03-23
Plain-language summary
The purpose of the study is to assess the average of the "State Anxiety" score of the State Trait Inventory Anxiety at the end of the third cycle of chemotherapy compared to the pre-treatment score (inclusion)
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient with cancer treated with adjuvant chemotherapy with an interval of 14 or 21 days for the first 3 cycles;
* Chemotherapy naïve patient;
* Patient speaking and understanding French and able to complete the questionnaires;
* Patient having been informed and having signed an informed consent form to participate in the study.
Exclusion Criteria:
* Patient who has already benefited from socio-aesthetic care;
* Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
* Patient unable to understand the information related to the study (linguistic, psychological, cognitive reasons, etc.);
* Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;
* Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;
* Patient not benefiting from a social security scheme.
What they're measuring
1
Change of mean of the "State Anxiety" score of the State Trait Inventory Anxiety
Timeframe: Between the inclusion and the end of the third cycle of chemotherapy (maximum cycle of 21 days)